Open letters

A letter has been sent to the WHO Regional Director for Europe, Zsuzsanna Jakab, to congratulate her with the good HIV and TB plans that are to be approved at the Regional Committee meeting in September.

An EATG letter to European Commissioner Karel de Gucht raising concerns relating to the availability and affordability of generic medicines to be discussed in the EU-India Free Trade Agreement negotiations

EATG letter sent to the Latvian government relating to Hepatitis C treatment.

Letter from EATG and partner organisations regarding civil society engagement to activities related to UNAIDS strategic plan.

The HIV community across Europe call on the European Commission, European Parliament and EU member states to express political leadership in combating HIV/AIDS in the EU and neighbouring countries

More than 50 community activists, researchers, clinicians, pharmaceutical representatives and regulatory authorities’ representatives met between the 3rd and 5th of June in Sitges, Spain, to discuss early and expanded access to new direct-acting antiviral drugs (DAAs) for people with hepatitis C.

Although the scientific community is presenting major advances at the 6th IAS conference that could end the HIV epidemic, some pharmaceutical companies are delaying treatment to millions of people living with HIV in developing countries.

AIDS Groups outraged as EU and US continue “immoral blackmail” on generic AIDS medicines through Free Trade Agreement Negotiations.

EATG expresses its shock and outrage at the Korean police and security guards’ actions—violently arresting peaceful demonstrators at the International Congress on AIDS in Asia and the Pacific (ICAAP) in Busan.

Busan, South Korea, 28 August 2011: Treatment activists, people living with hepatitis C, people who inject drugs and people living with HIV openly question the silence maintained by the World Health Organisation (WHO)

Statement on the Report of the ‘High-Level Independent Review Panel on Fiduciary Controls and Oversight Mechanism of the Global Fund to Fight AIDS Tuberculosis and Malaria’.

Brussels, 06.10.2011 - On Wednesday 12 October from 9.30 to 11.00 am, during the EACS conference in Belgrade, Serbia, the European AIDS Treatment Group (EATG) is organising the pre-opening satellite session “Advances in HIV biomedical prevention research: why involving the Community is key”.

The European AIDS Treatment Group (EATG) launches the “Emergency guidance on ART forced treatment interruptions due to drug unavailability (forced stock-outs) for people living with HIV and their care providers in Europe and Central Asia”.

Dangerous shortages of treatments and diagnostics are prime issue in the regions today.

Brussels, December 6th - “The HIV in Europe initiative welcomes the European Parliament resolution on the EU response to the HIV/AIDS epidemic in Europe and neighbouring countries adopted on World AIDS day.